Balaxi Pharmaceuticals Ltd Share Price(BALAXI)
Check the latest share price of Balaxi Pharmaceuticals Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹52.98
▲0.47%
as on 04:01PM, 23 May 2025
NSE
Balaxi Pharmaceuticals Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹52.3Day's Price Range₹53.7552 Week's Low
52 Week's High
₹50.4252-Week Price Range₹151.45
| Returns % | |
| 1 Month Return | -12.1 % |
| 3 Month Return | -6.31 % |
| 1 Year Return | -58.69 % |
| 3 Year Return | -37.9 % |
| 5 Year Return | + 159.45 % |
| Market Stats | |
| Previous Close | ₹52.73 |
| Open | ₹53.00 |
| Volume | 58.45K |
| Upper Circuit | ₹63.27 |
| Lower Circuit | ₹42.18 |
Balaxi Pharmaceuticals Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹292.49 Cr
Return on Equity (ROE)
3.42
PE Ratio (TTM)
10.47
Return on capital employed (ROCE)
5.99
Industry PE ratio
55.53
Beta (LTM)
1.16
P/B Ratio
4.59
Dividend Yield
0PEG Ratio
1.72
Quarterly Earnings Growth YOY
-60.56
EPS (TTM)
-0.438
Sector
Pharmaceuticals
Book Value
36.26
Technical Analysis
Bearish
View Technical Analysis
How to invest in Balaxi Pharmaceuticals Ltd?
Investing in Balaxi Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Balaxi Pharmaceuticals Ltd or BALAXI on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Balaxi Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Balaxi Pharmaceuticals Ltd with just a few clicks!
Balaxi Pharmaceuticals Ltd Stock's Interest Amongst Investors
Balaxi Pharmaceuticals Ltd Valuation
Track how the P/E of Balaxi Pharmaceuticals Ltd has moved over time to understand valuation trends.
Balaxi Pharmaceuticals Ltd in the last 5 years
Lowest (-263.96x)
May 28, 2024
Today (10.47x)
May 23, 2025
Industry (55.53x)
May 23, 2025
Highest (66.45x)
September 21, 2020
Today’s Price to Earnings Ratio: 10.47x
Balaxi Pharmaceuticals Ltd Financials
Get the annual and quarterly financial summary of Balaxi Pharmaceuticals Ltd, including revenue, profit, loss and more.
Balaxi Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Balaxi Pharmaceuticals Ltd.
Balaxi Pharmaceuticals Ltd Earnings Results
Balaxi Pharmaceuticals Ltd’s net profit fell -60.56% since last year same period to ₹5.36Cr in the Q3 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 16.78% jump in its net profits since last 3-months.
Read More about Earnings ResultsBalaxi Pharmaceuticals Ltd Dividends May,2022
In the quarter ending March 2022, Balaxi Pharmaceuticals Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.94%.
Read More about Dividends
Balaxi Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Balaxi Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 65.99% | 0.00 | |
| Foreign Institutions | 16.02% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 17.96% | 0.00 | |
| Others | 0.02% | 0.00 |
Balaxi Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Balaxi Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 292.49 | 31.89% | 0.56 | -3 | 241 | |
| NA | 778.19 | -6.53% | 0.56 | 41 | 338 | |
| NA | 25,186.31 | -3.2% | 0.50 | 772 | 5,664 | |
| NA | 101.85 | 15% | 0.55 | 5 | 75 | |
| NA | 19,898.75 | 31.77% | 0.51 | 161 | 1,295 |
Balaxi Pharmaceuticals Ltd News & Key Events
Latest news and events at one place to help you take investing decisions in Balaxi Pharmaceuticals Ltd.
Balaxi Pharma Shares Decline Amid Bulk Sale - 07 Apr, 2025
Balaxi Pharmaceuticals Limited's shares fell 6.86% to Rs. 62.41 following a bulk sale by EBISU Global Opportunities Fund of 2.98 lakh shares at Rs. 67.50. The company's revenue grew by 20.56%, but net profit decreased by 60.56% year-over-year.
Insights on Balaxi Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 17.50% to 17.96% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 59.14 Cr → 77.23 Cr (in ₹), with an average increase of 8.5% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 4.59 Cr → 5.36 Cr (in ₹), with an average increase of 14.4% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 65.99% of holdings in Mar 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 1 month, BALAXI stock has moved down by -12.1%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 16.48% to 16.02% in Mar 2025 quarter
About Balaxi Pharmaceuticals Ltd
In March 2017, Balaxi Overseas Pvt Ltd acquired 16,700,036 (54.94%) equity shares of the company along with its control and management. Its representatives became the new directors and the company was renamed to Balaxi Ventures. A preferential issue of 6,960,000 equity shares was approved in July 2019 and allotted in August, increasing the company’s paid-up share capital to Rs 100,000,000. Following this, Balaxi Ventures started international wholesale trading in pharmaceutical products, builders hardware, and recently launched YAP food products.
Revenue: ₹73.29Cr as on December 2024 (Q4 24)
Net Profit: ₹5.36Cr as on December 2024 (Q4 24)
Listing date: 30 Nov, 2015
Chairperson Name: Ashish Maheshwari
| Organisation | Balaxi Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Ashish Maheshwari |
| E-voting on shares | Click here to vote |
FAQs
What is Balaxi Pharmaceuticals Ltd price today?
Balaxi Pharmaceuticals Ltd share price today stands at ₹52.98, Open: ₹53, Previous Close: ₹52.73, High: ₹53.75, Low: ₹52.3, 52 Week High: ₹151.45, 52 Week Low: ₹50.42.
How to Buy Balaxi Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Balaxi Pharmaceuticals Ltd shares
What are today's traded volumes of Balaxi Pharmaceuticals Ltd?
Today's traded volume of Balaxi Pharmaceuticals Ltd(BALAXI) is 58.45K.
What is today's market capitalisation of Balaxi Pharmaceuticals Ltd?
Today's market capitalisation of Balaxi Pharmaceuticals Ltd(BALAXI) is ₹292.49 Cr.
What is the 52 Week High and Low Range of Balaxi Pharmaceuticals Ltd?
How much percentage Balaxi Pharmaceuticals Ltd is down from its 52 Week High?
Balaxi Pharmaceuticals Ltd (BALAXI) share price is ₹52.98. It is down -65.02% from its 52 Week High price of ₹151.45
How much percentage Balaxi Pharmaceuticals Ltd is up from its 52 Week low?
Balaxi Pharmaceuticals Ltd (BALAXI) share price is ₹52.98. It is up 5.08% from its 52 Week Low price of ₹50.42